Woodard & Company Asset Management Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.45M Buy
33,392
+774
+2% +$69.1K 0.5% 42
2026
Q1
$2.34M Buy
32,618
+1,394
+4% +$107K 0.37% 47
2025
Q4
$2.48M Buy
31,224
+2,841
+10% +$224K 0.39% 45
2025
Q3
$2.14M Buy
28,383
+3,721
+15% +$255K 0.35% 42
2025
Q2
$1.7M Sell
24,662
-472
-2% -$31K 0.31% 47
2025
Q1
$1.7M Buy
+25,134
New +$1.5M 0.36% 43
2018
Q1
Sell
-7
Closed 209
2017
Q4
$0 Buy
+7
New +$509 ﹤0.01% 223

Other funds holding CVS

Woodard & Company Asset Management Group's CVS Position: Q2 2026 in Review

Woodard & Company Asset Management Group increased its CVS Health (CVS) stake by 2.4% in Q2 2026, buying an estimated $69.1K and bringing the position to 33,392 shares worth $3.45M. The position accounts for 0.5% of the portfolio, ranked #42.

Woodard & Company Asset Management Group first reported a position in CVS in Q4 2017 and has held it in 7 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Woodard & Company Asset Management Group held 33,392 shares of CVS Health worth $3.45M as of Q2 2026.
  • Woodard & Company Asset Management Group bought 774 CVS Health shares in Q2 2026, an estimated $69.1K.
  • CVS Health made up 0.5% of Woodard & Company Asset Management Group's portfolio in Q2 2026, its #42 holding.
  • Woodard & Company Asset Management Group first reported a position in CVS Health in Q4 2017 and has held it in 7 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Woodard & Company Asset Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.